Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity

12
4
Favorite

Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity

T-Reuters2021-05-05

Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（4）

Elleysss
·2021-05-05
great!
Reply
Like
Report
VictorTan
·2021-05-05
Omg
Reply
1
Report
Bubu0106
·2021-05-05
Ohh
Reply
2
Report
Psi
·2021-05-05
Good
Reply
1
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2133542329?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-05-05 15:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2133542329","market":"us","top_or_hot":-1,"title":"Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity","media":"T-Reuters","content":"<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity\n</h2>\n\n<h4 class=\"meta\">\n\n2021-05-05 15:15 北京时间&nbsp;&nbsp;&nbsp;<strong>T-Reuters</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In ...</p>\n\n<a href=\"None\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":null,"article_id":"2133542329","we_media_id":"1086160438","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2133542329","pubTimestamp":1620198959,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"T-Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"summary":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Un","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"诺和诺德首席执行官说，我们可以看到肥胖症的增长又回来了","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{},"content_text":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.","kind":"highlight","is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":102668585,"gmtCreate":1620207764947,"gmtModify":1704340184202,"author":{"id":"3582775015485523","authorId":"3582775015485523","name":"Elleysss","avatar":"https://static.tigerbbs.com/fc575791aab67b344dbb075f41c1af57","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3582775015485523","authorIdStr":"3582775015485523"},"htmlText":"great!","listText":"great!","text":"great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102668585","repostId":2133542329,"repostType":4,"repost":{"id":"2133542329","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1620198959,"share":"https://ttm.financial/m/news/2133542329?lang=&edition=fundamental","pubTime":"2021-05-05 15:15","market":"us","language":"en","title":"Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2133542329","media":"T-Reuters","summary":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Un","content":"<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-05-05 15:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2133542329","content_text":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102634085,"gmtCreate":1620204328747,"gmtModify":1704340147834,"author":{"id":"3581643954540827","authorId":"3581643954540827","name":"VictorTan","avatar":"https://static.tigerbbs.com/e8f6af35b29d90a5cf41d25d71ee2335","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581643954540827","authorIdStr":"3581643954540827"},"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102634085","repostId":2133542329,"repostType":4,"repost":{"id":"2133542329","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1620198959,"share":"https://ttm.financial/m/news/2133542329?lang=&edition=fundamental","pubTime":"2021-05-05 15:15","market":"us","language":"en","title":"Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2133542329","media":"T-Reuters","summary":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Un","content":"<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-05-05 15:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2133542329","content_text":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102844240,"gmtCreate":1620200112280,"gmtModify":1704340096577,"author":{"id":"3575191923496169","authorId":"3575191923496169","name":"Bubu0106","avatar":"https://static.tigerbbs.com/d77c5b4980b3cb19d22f467d36ed248b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3575191923496169","authorIdStr":"3575191923496169"},"htmlText":"Ohh","listText":"Ohh","text":"Ohh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102844240","repostId":2133542329,"repostType":4,"repost":{"id":"2133542329","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1620198959,"share":"https://ttm.financial/m/news/2133542329?lang=&edition=fundamental","pubTime":"2021-05-05 15:15","market":"us","language":"en","title":"Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2133542329","media":"T-Reuters","summary":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Un","content":"<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-05-05 15:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2133542329","content_text":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102841305,"gmtCreate":1620199143107,"gmtModify":1704340088378,"author":{"id":"3562323522882055","authorId":"3562323522882055","name":"Psi","avatar":"https://static.tigerbbs.com/5487674b6e3f42f2c607f2eda9f34dbc","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3562323522882055","authorIdStr":"3562323522882055"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102841305","repostId":2133542329,"repostType":4,"repost":{"id":"2133542329","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1620198959,"share":"https://ttm.financial/m/news/2133542329?lang=&edition=fundamental","pubTime":"2021-05-05 15:15","market":"us","language":"en","title":"Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2133542329","media":"T-Reuters","summary":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Un","content":"<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk CEO Says We Can See That Growth Is Coming Back In Obesity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-05-05 15:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2133542329","content_text":"Novo Nordisk NOVOB.CO Chief Executive Lars Fruergaard Jorgensen on media conference call:Ceo Says Underlying, A Very Good Start To The Year For Novo Nordisk.Ceo Says We Have Improved Our Share In Diabetes Value Market To 29.3%.Ceo Says As The United States Is Gradually Coming Out Of Lockdown, We'Re Optimistic On Staying On A Positive Trajectory For Rybelsus.Ceo Says We Can See That Growth Is Coming Back In Obesity.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":12,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}